$SCOR

COMSCORE, INC. (SCOR): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

COMSCORE, INC. (SCOR) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. scor-20260616 0001158172 false 0001158172 2026-06-16 2026-06-16 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of report (Date of earliest event reported):

Original reporting
Published Jun 22, 2026, 11:17 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 23, 2026, 10:04 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefCorporate actions
Primary signal
$SCOR
Neutral
medium confidence
Mentioned
$SCOR
Relevance
6/10
alphai data visualization · based on SEC EDGAR 8-K
Decision brief

The 30-second read

$SCORNeutralLow
01

Why it matters

Stockholders approved the plan amendment at the June 16, 2026 annual meeting; the amendment became effective June 16. The filing also reports director elections and non-binding advisory approval of named executive officer compensation, plus ratification of Deloitte & Touche as auditor.

02

Market read

This is a governance/compensation update (equity plan share increase) with voting tallies; it is unlikely to drive a major repricing without accompanying financial or strategic changes.

03

What to watch

The 8-K includes voting results and plan effectiveness timing, but the text provided omits any details on actual officer departures/appointments beyond the plan amendment and director election—traders should verify whether any separate officer changes occurred under Item 5.02.

Relevance 6/10Novelty 4/10Timing: post-annual-meeting 8-K filed June 22, 2026 (plan amendment effective June 16)

Background

The company’s Board previously approved an amendment to its 2018 Equity and Incentive Compensation Plan to add 3,000,000 shares, subject to stockholder approval.

Company-level read

Ticker impact

$SCORNeutralMedium confidence
Context

comScore filed an 8-K confirming stockholder approval of a 3,000,000-share increase to its 2018 equity plan and director/election results.

Expected impact

Low near-term impact; any reaction likely limited to dilution/compensation optics rather than fundamentals.

Evidence & confidence

The filing is a routine post-annual-meeting 8-K (Items 5.02 and 5.07) with voting tallies and plan amendment effectiveness, but no new financial guidance, transactions, or enforcement actions.

Market effects

Minimal; equity-plan share increases are common among small/mid-cap software/media-tech firms and typically do not reset sector fundamentals.

None indicated; filing is company-specific and not tied to macro/regional policy.

None indicated; no cross-border transaction or regulatory action described.

Counterpoint

The plan share increase could still matter if the company accelerates equity-based compensation, potentially increasing future dilution versus what the market expects.

Key entities

  • comScore, Inc.

    NASDAQ-listed issuer filing the 8-K; subject of the director election and equity plan amendment vote.

  • Deloitte & Touche LLP

    Independent registered public accounting firm ratified for fiscal year ending Dec. 31, 2026.

Related articles

$SCORMed

Why is SCOR stock rallying today? By Investing.com

SCOR SE shares rose about 3.5% to 34.58 on Euronext Paris after the company reported Q2 2026 results. SCOR posted net income of EUR 171 million in Q2 and EUR 397 million for the first half, with a property and casualty combined ratio of 79.5%. Morgan Stanley named SCOR a preferred European insurance pick, citing potential capital release from Solvency II changes in Jan 2027.

$SCORMed

SCOR reports 24% drop in second quarter net income By Investing.com

SCOR SE reported Q2 net income of EUR 171 million, down 24% year over year, with insurance revenue down 5.1%. The property and casualty combined ratio improved to 79.5% on lower catastrophe losses and better attritional performance. Life and health service result was hurt by a one-off arbitration outcome. SCOR posted EUR 397 million net income in H1 2026 and expects continued competitive P&C reinsurance conditions.

$SCORMedAI 9/10

SCOR successfully places EUR 500 million subordinated notes maturing in 2056

SCOR SE said it has placed EUR 500 million fixed-to-floating rate subordinated notes maturing 5 June 2056, eligible as Solvency II Tier 2 capital. The notes pay 4.510% annually until 5 June 2036, then 3-month EURIBOR plus a margin quarterly, with possible interest deferral. Moody’s rates them A3. Proceeds will fund general purposes and a concurrent EUR 250 million tender for 2047 notes; settlement expected 5 June 2026.

$SCORMedAI 9/10

SCOR announces the launch of a cash tender offer and its intention to issue new subordinated notes

SCOR SE said it launched a cash tender offer to buy EUR 250m Fixed to Reset Subordinated Notes due 2047 (ISIN FR0012770063; EUR 250m outstanding) and EUR 500m Fixed to Reset Subordinated Notes due 2048 (ISIN FR0013179314; EUR 500m outstanding). The offer runs 27 May–3 June 2026. SCOR also intends to issue new Tier 2-eligible subordinated notes, with proceeds funding the tender, subject to market conditions.